Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum

European Journal of Pharmacology

Volumn 461, Issue 2-3, 2003, Pages 105-111

  Dobrev, Dobromir ^a   Ravens, Ursula ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Dopamine release; Neomycin; Striatum; Veratridine; Agatoxin IVA; Conotoxin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AMINOGLYCOSIDE ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM ION; DOPAMINE; NEOMYCIN; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIC; POTASSIUM ION; RYANODINE; THAPSIGARGIN; TRITIUM; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; EVOKED RESPONSE; IC 50; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM;

EID: 0037436053     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01319-0     Document Type: Article

References (38)

1. Atchison W.D., Adgate L., Beaman C.M. Effects of antibiotics on uptake of calcium into isolated nerve terminals. J. Pharmacol. Exp. Ther. 245:1988;394-401.
2. Bergquist F., Jonason J., Pileblad E., Nissbrandt H. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J. Neurochem. 70:1998;1532-1540.
3. 2+ antiporter in brain nerve endings. Eur. J. Pharmacol. 245:1993;97-103.
4. 2+ channels. Brain Res. 669:1995;234-244.
5. Chambers H.F. The aminoglycosides. Hardman J.G., Limbird L.E., Goodman Gilman A. The Pharmacological Basis of Therapeutics. 2001;1219-1238 McGraw-Hill, New York.
6. Davis R.R., Brummett R.E., Bendrick T.W., Himes D.L. Dissociation of maximum concentration of kanamycin in plasma and perilymph from ototoxic effect. J. Antimicrob. Chemother. 14:1984;291-302.
7. +- and veratridine-stimulated noradrenaline release in rat brain slices and rat brain synaptosomes. FEBS Lett. 219:1987;445-450.
8. 3H]dopamine release from rat striatal slices by voltage-activated calcium channel ligands: effects of ω-conotoxin-MVIIC. Neurochem. Res. 22:1997;1085-1093.
9. 3H]dopamine in rat striatal slices. Neuropharmacology. 37:1998;973-982.
10. Dobrev D., Milde A.S., Andreas K., Ravens U. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum. Br. J. Pharmacol. 127:1999;576-582.
11. i responses to membrane depolarization. Neurochem. Int. 28:1996;67-75.
12. Elverfors A., Jonason J., Jonason G., Nissbrandt H. Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices. Synapse. 26:1997;359-369.
13. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Ann. N.Y. Acad. Sci. 884:1999;99-109.
14. Gabev E., Kasianowicz J., Abbott T., McLaughlin S. Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2). Biochim. Biophys. Acta. 979:1989;105-112.
15. Gaborjan A., Halmos G., Repassy G., Vizi E.S. A new aspect of aminoglycoside ototoxicity: impairment of cochlear dopamine release. NeuroReport. 12:2001;3327-3330.
16. 2+ channel, and it is functionally important in renal afferent arterioles. Circ. Res. 87:2000;896-902.
17. Jenden D.J., Fairhurst A.S. The pharmacology of ryanodine. Pharmacol. Rev. 21:1969;1-25.
18. Keith R.A., Mangano T.J., DeFeo P.A., Horn M.B., Salama A.I. Actions of neomycin on neuronal L-, N-, and non-L/non-N-type voltage-sensitive calcium channel responses. J. Mol. Neurosci. 3:1992;147-154.
19. 125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;583-586.
20. 2+ channel current in rat arterial smooth muscle. Pflugers Arch. 433:1996;188-193.
21. 2+-pump by negatively charged phospholipids. Gen. Physiol. Biophys. 11:1992;567-577.
22. Mack W.M., Zimanyi I., Pessah I.N. Discrimination of multiple binding sites for antagonists of the calcium release channel complex of skeletal and cardiac sarcoplasmic reticulum. J. Pharmacol. Exp. Ther. 262:1992;1028-1037.
23. 2+ entry in melanotropic cells. J. Neurophysiol. 87:2002;793-801.
24. Mermelstein P.G., Foehring R.C., Tkatch T., Song W.J., Baranauskas G., Surmeier D.J. Properties of Q-type calcium channels in neostriatal and cortical neurons are correlated with beta subunit expression. J. Neurosci. 1999;7268-7277.
25. Mintz I.M., Adams M.E., Bean B.P. P-type calcium channels in rat central and peripheral neurons. Neuron. 9:1992;85-95.
26. Moore E.W. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes. J. Clin. Invest. 49:1970;318-334.
27. Myles M.E., Fain J.N. Carbachol, but not norepinephrine, NMDA, ionomycin, ouabain, or phorbol myristate acetate, increases inositol 1,3,4,5-tetrakisphosphate accumulation in rat brain cortical slices. J. Neurochem. 62:1994;2333-2339.
28. Olivera B.M., Miljanich G.P., Ramachandran J., Adams M.E. Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins. Ann. Rev. Biochem. 63:1994;823-867.
29. Perrier M.L., Scatton B., Benavides J. Dihydropyridine- and omega-conotoxin-resistant, neomycin-sensitive calcium channels mediate the depolarization-induced increase in internal calcium levels in cortical slices from immature rat brain. J. Pharmacol. Exp. Ther. 261:1992;324-330.
30. Pichler M., Wang Z., Grabner-Weiss C., Reimer D., Hering S., Grabner M., Glossmann H., Striessnig J. Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35:1996;14659-14664.
31. Protti D.A., Reisin R., Mackinley T.A., Uchitel O.D. Calcium channel blockers and transmitter release at the normal human neuromuscular junction. Neurology. 46:1996;1391-1396.
32. Sayers L.G., Michelangeli F. The inhibition of the inositol 1,4,5-trisphosphate receptor from rat cerebellum by spermine and other polyamines. Biochem. Biophys. Res. Commun. 197:1993;1203-1208.
33. 3H]dopamine release from rat striatal synaptosomes. J. Neurochem. 67:1996;163-170.
34. 125I]omega-conotoxin GVIA binding to neuronal membranes by neomycin may be mediated by a GTP-binding protein. Eur. J. Pharmacol. 206:1991;155-158.
35. 2+-ATPase. Proc. Natl. Acad. Sci. U. S. A. 87:1990;2466-2470.
36. Toner C.C., Stamford J.A. Involvement of N- and P/Q- but not L- or T-type voltage-gated calcium channels in ischaemia-induced striatal dopamine release in vitro. Brain Res. 748:1997;85-92.
37. 2+ channels in supporting hippocampal synaptic transmission. Science. 264:1994;107-111.
38. 2+ channels in the kidney. Proc. Natl. Acad. Sci. U. S. A. 89:1992;10494-10498.